D., G. Avallone, R. Ferrari, et al. 2011. Canine cutaneous perivascular wall tumors at first presentation: Clinical behavior and prognostic factors in 55 cases. J Vet Intern Med 25(6):1398–1405.365 Stefanello, D., P. Valenti, S. Faverzani, et al. 2009. Ultrasound‐guided cytology of spleen and liver: A prognostic tool in canine cutaneous mast cell tumor. J Vet Intern Med 23(5):1051–1057.
366 Stefanello, D., P. Buracco, S. Sabattini, et al. 2015. Comparison of 2‐and 3‐category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009–2014). J Am Vet Med Assoc 246(7):765–769.
367 Straw, R.C., S.J. Withrow, and B.E. Powers. 1992. Partial or total hemipelvectomy in the management of sarcomas in nine dogs and two cats. Vet Surg 21(3):183–188.
368 Sugiyama, A., T. Morita, A. Shimada, et al. 2008. Primary malignant peripheral nerve sheath tumor with eosinophilic cytoplasmic globules arising from the greater omentum in a dog. J Vet Med Sci 70(7):739–742.
369 Suzuki, S., K. Uchida, and H. Nakayama. 2014. The effects of tumor location on diagnostic criteria for canine malignant peripheral nerve sheath tumors (MPNSTs) and the markers for distinction between canine MPNSTs and canine perivascular wall tumors. Vet Pathol 51(4):722–736.
370 Swaim, S.F. 2003. Chapter 24—Skin grafts. In Textbook of Small Animal Surgery, 3rd edition. D.H. Slatter, editor. Philadelphia: Saunders.
371 Szivek, A., R.E. Burns, B. Gericota, et al. 2012. Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993–2007. Vet Comp Oncol 10(1):65–73.
372 Teixeira, S., I. Amorim, A. Rêma, et al. 2016. Molecular heterogeneity of canine cutaneous peripheral nerve sheath tumors: A drawback in the diagnosis refinement. In Vivo 30(6):819–827.
373 Terry, J.L., M. Milovancev, C.V. Löhr, et al. 2016. Changes in the dimension and volume of feline injection‐site sarcomas following formalin fixation as determined by use of the ellipsoid volume formula and three‐dimensional computed tomography software. Am J Vet Res 77(6):620–626.
374 Terry, J.L., M. Milovancev, S. Nemanic, et al. 2017. Quantification of surgical margin length changes after excision of feline injection site sarcomas‐A pilot study. Vet Surg 46(2):189–196.
375 Thamm, D.H., E.A. Mauldin, and D.M. Vail. 1999. Prednisone and vinblastine chemotherapy for canine mast cell tumor – 41 cases (1992–1997). J Vet Intern Med 13(5):491–497.
376 Thamm, D.H., M.M. Turek, and D.M. Vail. 2006. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high‐risk canine mast cell tumor: 61 cases. J Vet Med Sci 68(6):581–587.
377 Theilen, G.H. and B.R. Madewell. 1979. Veterinary Cancer Medicine. Philadelphia: Lea & Febiger.
378 Thompson, J.J., D.L. Pearl, J.A. Yager, et al. 2011. Canine subcutaneous mast cell tumor: Characterization and prognostic indices. Vet Pathol 48(1):156–168.
379 Thongtharb, A., J.K. Chambers, K. Uchida et al. 2015. Lymphangiosarcoma with systemic metastases in a Japanese domestic cat. J Vet Med Sci 77(3):371–374.
380 Thornton, K. 2008. Chemotherapeutic management of soft tissue sarcoma. Surg Clin North Am 88(3):647–660, viii.
381 Torrigiani, F., A. Pierini, R. Lowe, et al. 2019. Soft tissue sarcoma in dogs: A treatment review and a novel approach using electrochemotherapy in a case series. Vet Comp Oncol 17:234–241.
382 Trappler, M.C., C.A. Popovitch, M.H. Goldschmidt, et al. 2014. Scrotal tumors in dogs: A retrospective study of 676 cases (1986–2010). Can Vet J 55(1):1229–1233.
383 Trout, N.J., M.M. Pavletic, and K.H. Kraus. 1995. Partial scapulectomy for management of sarcomas in three dogs and two cats. J Am Vet Med Assoc 207(5):585–587.
384 Tsioli, V., L.G. Papazoglou, N. Papaioannou, et al. 2015. Comparison of three skin‐stretching devices for closing skin defects on the limbs of dogs. J Vet Sci 16:99–106.
385 Tsuji, N., S. Furukawa, and K. Ozaki. 2013. Cutaneous hemangiosarcoma in a dog. J Toxicol Pathol 26(2):193–195.
386 Tuohy, J.L., J. Milgram, D.R. Worley, et al. 2009. A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology. Vet Comp Oncol7(2):81–91.
387 Turek, M., R. Gogal Jr, C. Saba, et al. 2014. Masitinib mesylate does not enhance sensitivity to radiation in three feline injection‐site sarcoma cell lines under normal growth conditions. Res Vet Sci 96(2):304–307.
388 Turrel, J.M., J. Farrelly, R.L. Page, et al. 2006. Evaluation of strontium 90 irradiation in treatment of cutaneous mast cell tumors in cats: 35 cases (1992–2002). J Am Vet Med Assoc 228(6):898–901.
389 Turrel, J.M., B.E. Kitchell, L.M. Miller, et al. 1988. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 193(8):936–940.
390 Upchurch, D.A., E.E. Klocke, and J.N. Henningson. 2018. Amount of skin shrinkage affecting tumor versus grossly normal marginal skin of dogs for cutaneous mast cell tumors excised with curative intent. Am J Vet Res 79(7):779–786.
391 Vail, D.M. and S.J. Withrow. 2007. Tumors of the skin and subcutaneous tissues. In Withrow & MacEwen’s Small Animal Clinical Oncology, 4th edition, pp. 375–401. S.J. Withrow and E.G. MacEwen, editors. St. Louis: Saunders Elsevier.
392 Vail, D., D. Thamm, and J. Liptak. 2019. Withrow and MacEwen’s Small Animal Clinical Oncology. St. Louis: Saunders.
Vet J
1 Vascellari, M., E. Melchiotti, E. Bozza et al. 2003. Fibrosarcomas at presumed sites of injection in dogs: Characteristics and comparison with non‐vaccination site sarcomas and feline post‐vaccinal fibrosarcomas. J Vet Med A Physiol Pathol Clin Med 50(6):286–291.
2 Vascellari, M., E. Melchiotti, and F. Mutinelli. 2006. Fibrosarcoma with typical features of postinjection sarcoma at site of microchip implant in a dog: Histologic and immunohistochemical study. Vet Pathol 43(4):545–548.
3 Verganti, S., D. Berlato, L. Blackwood, et al. 2017. Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK. J Small Anim Pract 58(1):10–16.
4 Vickery, K.R., H. Wilson, D.M. Vail, et al. 2008. Dose‐escalating vinblastine for the treatment of canine mast cell tumor. Vet Comp Oncol 6(2):111–119.
5 Villamil, J.A., C.J. Henry, and J.N. Bryan. 2011. Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms. J Am Vet Med Assoc 239(7):960–965.
6 Villamill, J.A., C.J.Henry, J.N. Bryan, et al. 2011. Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms. J Am Vet Med Assoc 239(7):960–965.
7 Villedieu, E.J., A.F. Petite, J.D. Godolphin, et al. 2021. Prevalence of pulmonary nodules suggestive of metastasis at presentation in dogs with cutaneous or subcutaneous soft tissue sarcoma. J Am Vet Med Assoc 258:179–185.
8 Ward, H., L.E. Fox, M.B. Calderwood‐Mays, et al. 1994. Cutaneous hemangiosarcoma in 25 dogs: A retrospective study. J Vet Intern Med 8(5):345–348.
9 Warland, J., I. Amores‐Fuster, W. Newbury,
